ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical Trials

Annals of Surgical Oncology - Tập 30 - Trang 7384-7385 - 2023
Shin Kobayashi1, Masafumi Ikeda2, Kohei Nakachi3, Makoto Ueno4, Takuji Okusaka5, Akiko Todaka6, Sohei Satoi7, Akira Tomokuni8, Masaru Konishi1, Junji Furuse4,9
1Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Japan
2Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan
3Department of Medical Oncology, Tochigi Cancer Center, Tochigi, Japan
4Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan
5Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
6Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
7Department of Surgery, Kansai Medical University, Hirakata, Japan
8Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan
9Department of Medical Oncology, Faculty of Medicine, Kyorin University, Tokyo, Japan

Tài liệu tham khảo

Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2023;401(10372):195–203. https://doi.org/10.1016/S0140-6736(22)02038-4. Kobayashi S, Ikeda M, Nakachi K, et al. A multicenter survey on eligibility for a randomized, phase III trial of adjuvant chemotherapy for resected biliary tract cancer (JCOG1202, ASCOT). Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13913-6
Thông tin
Thông tin xuất bản

Annals of Surgical Oncology

Tập 30

7384-7385

Thông tin tác giả